Bolt Biotherapeutics CMO, Dr. Edith Perez, and VP of CMC & Quality, Dr. Nathan Ihle, bring patient and production process expertise to the table for a conversation with Business of Biotech on preparing CMC for an IND and ensuing first in-human studies. Listen now and subscribe so you never miss an episode.
By Geetha Yadav and Kenneth Oh,Bio-Rad Laboratories, Inc.
Normalization using total proteins present in the sample has gained significant traction and has proved to be a reliable method for normalization of western blots. This infographic illustrates why the total protein normalization (TPN) method is superior and the way to go for western blotting.